Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas
- 1 July 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 362 (9379), 230-232
- https://doi.org/10.1016/s0140-6736(03)13915-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Primary Chemoprevention of Familial Adenomatous Polyposis with SulindacNew England Journal of Medicine, 2002
- Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemopreventionThe Lancet Oncology, 2002
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI Journal of the National Cancer Institute, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Effect of sulindac on sporadic colonic polypsGastroenterology, 1995
- Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposisBritish Journal of Surgery, 1993
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993
- Sulindac causes regression of rectal polyps in familial adenomatous polyposisGastroenterology, 1991